Active Awards Portfolio Dashboard

It takes a lot of effort to develop a promising stem cell research idea into an effective treatment that can help patients. CIRM funds a pipeline of projects spanning discovery, translation and clinical stage research. Check out our portfolio of active research awards in our interactive dashboard below. For a detailed list of CIRM-funded clinical trials, visit our Clinical Trials Dashboard.

Filter Awards

Diseasesort descending Cell Type Therapeutic or Technology Institution Stage Project Objective Details
Age-related macular degeneration Embryonic Stem Cell Donor cell therapy USC
Clinical Trial, Phase 1 or Phase 1/2
Age-related macular degeneration iPS Cell Personalized cell therapy UCLA
Pre-IND/IDE or Equivalent
Age-related macular degeneration iPS Cell Exploring disease mechanisms UCSD
Research Insights
Age-related macular degeneration Adult Stem Cell Donor cell therapy Stanford
Pre-IND/IDE or Equivalent
Alpha Thalassemia Major Adult Stem Cell Donor cell therapy UCSF
Clinical Trial, Phase 1 or Phase 1/2
Alzheimer's Disease Embryonic Stem Cell,
iPS Cell
Small molecule therapy Salk
Pre-IND/IDE or Equivalent
Amyotrophic Lateral Sclerosis,
Spinal Cord Injury,
Spinal Muscular Atrophy
Embryonic Stem Cell Model system development UCLA
Tool/Resources/Bottleneck
Amyotrophic Lateral Sclerosis,
Spinal Cord Injury
Embryonic Stem Cell,
iPS Cell
Cell imaging & tracking UCSD
Research Insights
Amyotrophic Lateral Sclerosis Adult Stem Cell Gene-modified, personalized cell therapy BrainStorm
Clinical Trial, Phase 3
Amyotrophic Lateral Sclerosis Adult Stem Cell Gene-modified, donor cell therapy Cedars-Sinai
Clinical Trial, Phase 1 or Phase 1/2
Arthritis,
Osteoarthritis
Adult Stem Cell Small molecule therapy Calibr
Clinical Trial, Phase 1 or Phase 1/2
Autism Adult Stem Cell Gene-modified, donor cell therapy UC Davis
Development Candidate, Proof of Concept
Autism iPS Cell Small molecule therapy Scripps
Development Candidate, Proof of Concept
B cell cancers,
Leukemia
Cancer Stem Cell Antibody COH
Development Candidate, Proof of Concept
B cell cancers,
Leukemia
Adult Stem Cell Gene-modified, personalized cell therapy Stanford
Clinical Trial, Phase 1 or Phase 1/2
B cell cancers,
Leukemia
Cancer Stem Cell Antibody UCSD
Clinical Trial, Phase 1 or Phase 1/2
Beta Thalassemia Adult Stem Cell Gene-modified, personalized cell therapy Sangamo
Clinical Trial, Phase 1 or Phase 1/2
Beta Thalassemia,
Sickle Cell Disease
Adult Stem Cell Diagnostic Test CHORI
Regulated Lab Test, Ready for Validation
Bladder or Urinary Tract Disorder,
Incontinence
iPS Cell Personalized cell therapy Stanford
Pre-IND/IDE or Equivalent
Bladder or Urinary Tract Disorder,
Solid Tumors
Embryonic Stem Cell Donor cell therapy Stanford
Development Candidate, Proof of Concept
Blood Disorders Adult Stem Cell Cell processing & handling UCSF
Tool/Resources/Bottleneck
Blood Disorders iPS Cell Model system development Stanford
Research Insights, Tool/Resources/Bottleneck
Blood Disorders,
Blood Cancer
Adult Stem Cell Small molecule therapy UCLA
Development Candidate
Blood Disorders Adult Stem Cell Cell processing & handling Stanford
Research Insights
Blood Disorders Embryonic Stem Cell Specific Cell Type Derivation UCLA
Tool/Resources/Bottleneck
Blood Disorders Adult Stem Cell Exploring stem cell mechanisms UCLA
Development Candidate, Proof of Concept, Research Insights
Blood Disorders Adult Stem Cell Gene-modified, personalized cell therapy UCLA
Development Candidate, Proof of Concept
Blood Disorders Embryonic Stem Cell Donor cell therapy UCSF
Research Insights
Blood Disorders,
Immune Disease
Adult Stem Cell Gene-modified, personalized cell therapy Stanford
Development Candidate
Blood Cancer,
Bone Marrow Transplant and Viral Infection
Adult Stem Cell Donor cell therapy CHLA
Clinical Trial, Phase 1 or Phase 1/2
Blood Cancer,
Ovarian Cancer
iPS Cell Donor cell therapy UCSD
Development Candidate
Blood Cancer Adult Stem Cell Donor cell therapy Angiocrine
Clinical Trial, Phase 1 or Phase 1/2
Blood Cancer Adult Stem Cell Gene-modified, donor cell therapy Angiocrine
Clinical Trial, Phase 1 or Phase 1/2
Bone or Cartilage Disease Adult Stem Cell Donor cell therapy UCLA
Proof of Concept
Bone or Cartilage Disease Embryonic Stem Cell Donor cell therapy Scripps Health
Pre-IND/IDE or Equivalent
Bone or Cartilage Disease Embryonic Stem Cell Donor cell therapy USC
Pre-IND/IDE or Equivalent
Bone or Cartilage Disease Adult Stem Cell Small molecule therapy MAX BioPharma, Inc.
Pre-IND/IDE or Equivalent
Bone or Cartilage Disease Adult Stem Cell Cell imaging & tracking UC Davis
Tool/Resources/Bottleneck
Bone or Cartilage Disease Adult Stem Cell Tissue engineering Stanford
Proof of Concept, Research Insights
Bone or Cartilage Disease iPS Cell Donor cell therapy Cedars-Sinai
Proof of Concept, Research Insights
Brain Cancer Adult Stem Cell Gene-modified, personalized cell therapy UCSF
Development Candidate, Proof of Concept
Brain Cancer Cancer Stem Cell Vaccine Stanford
Pre-IND/IDE or Equivalent
Brain Cancer Adult Stem Cell Gene-modified, personalized cell therapy COH
Clinical Trial, Phase 1 or Phase 1/2
Brain Cancer Adult Stem Cell Gene-modified, personalized cell therapy COH
IND
Canavan Disease iPS Cell Gene-modified, personalized cell therapy COH
Pre-IND/IDE or Equivalent
Cancer Adult Stem Cell Gene-modified, donor cell therapy UCLA
Development Candidate, Proof of Concept
Cancer Cancer Stem Cell Gene-modified, personalized cell therapy UCSD
Pre-IND/IDE or Equivalent
Cancer Embryonic Stem Cell Donor cell therapy UCLA
Tool/Resources/Bottleneck
Cancer Adult Stem Cell Personalized cell therapy UCLA
Pre-IND/IDE or Equivalent
Heart Disease Directly Reprogrammed Cell Gene modification Gladstone
Proof of Concept

Pages

Icon for csv export